The ageing of the population has been accompanied by an increased burden of medical expenses and more complex and diversified medical needs. In the face of that, we are dedicated to researching and developing new bio drugs which are potentially effective against previously hard-to-treat symptoms, as well as biosimilars which are expected to reduce medical expenses and regenerative medicine which contains the promise of a wealth of new medical treatment possibilities.
Japan Regenerative Medicine
We have started clinical trials of JRM-001, a pioneering product selected with the hopes of becoming the first regenerative medical product in practical use in the world for treating pediatric patients with congenital heart disease. JRM-001 is just the beginning, and we are still working on various other challenging tasks with the aim of becoming a leading company in regenerative medicine.